EC Number   |
Title |
Organism |
|---|
    1.17.4.4 | A case study of acenocoumarol sensitivity and genotype-phenotype discordancy explained by combinations of polymorphisms in VKORC1 and CYP2C9 |
Homo sapiens |
| 1.17.4.4 | A hetero-dimer model for concerted action of vitamin K carboxylase and vitamin K reductase in vitamin K cycle |
Homo sapiens |
| 1.17.4.4 | A homologue of vitamin K epoxide reductase in Solanum lycopersicum is involved in resistance to osmotic stress |
Solanum lycopersicum |
| 1.17.4.4 | A molecular mechanism for genetic warfarin resistance in the rat |
Rattus norvegicus |
| 1.17.4.4 | A new cell culture-based assay quantifies vitamin K 2,3-epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven VKOR assay |
Homo sapiens |
| 1.17.4.4 | A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase |
Homo sapiens |
| 1.17.4.4 | A quantum chemical study of the mechanism of action of Vitamin K epoxide reductase (VKOR) II. Transition states |
Homo sapiens |
| 1.17.4.4 | A rapid genotyping method for the vitamin K epoxide reductase complex subunit 1 (VKORC1) gene |
Homo sapiens |
| 1.17.4.4 | A vitamin K epoxide reductase complex subunit 1 mutation in an Irish patient with warfarin resistance |
Homo sapiens |
| 1.17.4.4 | Altered Escherichia coli membrane protein assembly machinery allows proper membrane assembly of eukaryotic protein vitamin K epoxide reductase |
Rattus norvegicus |
